schrodinger.com - SDGR Enterprise Value-to-Sales Ratio

Official company branding of schrodinger.com (SDGR)

The price-to-sales ratio of Schrodinger, Inc. (SDGR) demonstrates the impact of the struggle against bio-AI tech giants, with the value of 6347.70 reflecting this status. This trend is supported by continuous software updates and the development of proprietary medications. The result is the automation of drug formula discovery via algorithms that replace the routine labor of scientists in laboratories.

Schrodinger Corp (SDGR): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/20/2026

Schrodinger Corp - analytical breakdowns and key metrics (SDGR)

- share price and consensus valuation forecast:
Initial company analysis:Schrodinger, Inc., SDGR
Product sample of Schrödinger Inc.

For Schrodinger, Inc., amid the digitalization of analytics, the EV/Sales multiple trend serves as an indicator of fundamental stability. This metric compares the total enterprise value, including debt, with annual sales volume, excluding the influence of capital structure. The current value of 6347.70 reflects the market's valuation of revenue generation efficiency. This chart's price action allows for the differentiation of random fluctuations from systemic shifts. High demand for software confirms the justification of the asset's current valuation.

Competitor analysis for Schrodinger, Inc.

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|GDRX - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume PHR|OMDA: EV/Sales Multiple|Evolent Health, Inc. - Business Value to Revenue|Enterprise Value-to-Revenue Ratio HealthStream Corp|DH: Business Value to Revenue|Company Value to Revenue CCSI (Consensus)|Total Company Value-to-Revenue Ratio Agilon Health|EV/Sales Multiple ABSI (Absci)|soyoung.com (SY) - Enterprise Value-to-Revenue Multiple|NRC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)